Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Dermatology

Life After Diagnosis: Monitoring and Quality of Life

At a Glance

Long-term management of Discoid Lupus Erythematosus (DLE) requires regular skin checks to monitor for rare skin cancers in old scars and progression to systemic lupus. Strict sun protection, emerging scar treatments, and mental health support are crucial for maintaining your quality of life.

Living with Discoid Lupus Erythematosus (DLE) is a marathon, not a sprint. While the initial goal is to stop active inflammation, the long-term focus shifts to monitoring for complications, managing permanent changes like scarring, and protecting your emotional well-being.

Monitoring for Long-Term Complications

While DLE is primarily a skin disease, chronic inflammation over many years can lead to rare but serious complications.

The Risk of Skin Cancer

In rare cases, long-standing, chronic DLE scars can undergo a “malignant transformation” into Squamous Cell Carcinoma (SCC), a type of skin cancer [1][2]. This typically happens in scars that have been present for many years and have been exposed to repeated sun damage or persistent inflammation [2][3].

Warning Signs to Watch For:

  • A new, rapidly growing bump or nodule inside an old scar [4][5].
  • An ulcer or sore that bleeds easily and refuses to heal [4][6].
  • A change in the texture or “feel” of a stable, long-standing patch.

If you notice any of these “red flags,” it is essential to have your dermatologist examine the area immediately.

Continued Systemic Monitoring

Even if your DLE has been stable for years, your care team will continue to monitor you for signs of Systemic Lupus Erythematosus (SLE). This is especially important if you have generalized DLE (lesions on both the face and body) or a positive ANA (antinuclear antibody) blood test, as these are known risk factors for systemic progression [7][8].

Navigating the Psychological Impact

The visible nature of DLE—especially when it causes permanent scarring or alopecia (hair loss)—can carry a heavy emotional weight [9][10].

  • Social Isolation: Many patients report feelings of stigmatization or a desire to withdraw from social situations due to changes in their appearance [11].
  • Validity of Distress: It is common and medically recognized to experience depressive symptoms or anxiety related to DLE [11][12]. These feelings are not “vain”; they are a direct result of the disease’s impact on your life.
  • Seeking Support: Quality-of-life tools are now used by many doctors to help measure the psychosocial burden of the disease [13]. Don’t hesitate to ask your doctor for a referral to a therapist or a support group that specializes in chronic skin conditions.

Emerging Treatments for Scarring

For many years, it was believed that once a DLE scar formed, nothing could be done to restore hair or skin texture. However, new research is beginning to offer hope:

  • JAK Inhibitors: Newer medications like tofacitinib are being studied for their ability to calm “refractory” (stubborn) DLE and may even help prevent further hair loss in some patients [14][15].
  • Platelet-Rich Fibrin (PRF): This is an emerging regenerative therapy where a patient’s own blood is processed to create a concentrated “plug” of healing factors. Early studies are exploring whether PRF can help with symptom control or even limited hair regrowth in areas of scarring alopecia [16][17].
  • Sun Protection as Prevention: The most effective “treatment” for long-term scarring remains lifelong, aggressive sun protection. Preventing the inflammation that causes the scar is the best way to maintain your skin’s health over the decades [18].

Your Long-Term Strategy

Managing DLE successfully means staying connected with your medical team. Regular skin checks, routine blood work, and open communication about your mental health are the pillars of a high quality of life with this condition.

Common questions in this guide

Can old DLE scars turn into skin cancer?
Yes, in rare cases, long-standing DLE scars can develop into a type of skin cancer called Squamous Cell Carcinoma (SCC). This typically occurs in older scars exposed to repeated sun damage, so you should monitor for new bumps or non-healing sores.
Will my DLE turn into systemic lupus?
While DLE is primarily a skin condition, your care team will monitor you for signs of Systemic Lupus Erythematosus (SLE). The risk of developing systemic lupus is higher if you have generalized DLE on your body or a positive ANA blood test.
Are there any treatments for hair loss caused by DLE scarring?
Historically, permanent scarring and hair loss from DLE were considered irreversible. However, emerging treatments like JAK inhibitors and Platelet-Rich Fibrin (PRF) are currently being researched for their potential to help with symptom control and limited hair regrowth.
How can I cope with the emotional impact of visible DLE scars?
The visible changes and hair loss caused by DLE can lead to valid feelings of anxiety, depression, and social isolation. It is highly recommended to speak with your doctor about these feelings, as they can refer you to a therapist or support group specializing in chronic skin conditions.
What are the warning signs of skin cancer in a DLE scar?
Warning signs include a new, rapidly growing bump inside an old scar, a sore that bleeds easily and won't heal, or a change in the texture of a long-standing patch. If you notice any of these red flags, contact your dermatologist immediately.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.I have a very old scar that has started to bleed and won't heal; could this be a sign of skin cancer?
  2. 2.What is the most effective way for me to monitor my chronic scars at home?
  3. 3.Are there any local specialists who focus on the psychological impact of visible skin conditions?
  4. 4.Am I a candidate for emerging treatments like PRF or JAK inhibitors to help with my hair loss?
  5. 5.How often should we be doing follow-up blood work to monitor for systemic progression?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Squamous cell carcinoma on the lip arising from discoid lupus erythematosus: a case report and review of Japanese patients.

    Makita E, Akasaka E, Sakuraba Y, et al.

    European journal of dermatology : EJD 2016; (26(4)):395-6 doi:10.1684/ejd.2016.2780.

    PMID: 27046922
  2. 2

    Mucosal Cancers Arising in Potentially Malignant Lesions of the Oral Mucosa Are Marjolin Ulcers: New Insights Into Old Concepts.

    Guedes NL, Lourenço SV, Nico MMS

    Dermatology practical & conceptual 2024; (14(3)) doi:10.5826/dpc.1403a210.

    PMID: 39122536
  3. 3

    Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus.

    Zaalberg A, Moradi Tuchayi S, Ameri AH, et al.

    The Journal of investigative dermatology 2019; (139(1)):62-70 doi:10.1016/j.jid.2018.06.185.

    PMID: 30030152
  4. 4

    Squamous Cell Cancer Arising in an African American Male Cheek from Discoid Lupus: A Rare Case and Review of the Literature.

    Shapera EA, Kim PD

    Case reports in surgery 2016; (2016()):9170424 doi:10.1155/2016/9170424.

    PMID: 27610262
  5. 5

    Neglect leads to extremes: maggots and malignancy in a case of discoid lupus erythematosus.

    Bhari N, Khaitan BK, Gupta P, et al.

    Lupus 2016; (25(1)):97-101 doi:10.1177/0961203315603145.

    PMID: 26345675
  6. 6

    Eruptive Keratoacanthoma-Like Discoid Lupus Erythematosus.

    Georgesen C, Magro C

    The American Journal of dermatopathology 2018; (40(6)):423-427 doi:10.1097/DAD.0000000000000971.

    PMID: 28816744
  7. 7

    Persistent red and swollen eyelids.

    Maya Y, Tashimo A, Ota M

    Lancet (London, England) 2018; (392(10157)):1552 doi:10.1016/S0140-6736(18)32327-4.

    PMID: 30496061
  8. 8

    Cutaneous lupus erythematosus - from pathogenesis to targeted therapy.

    Klein B, Billi AC, Abernathy-Close L, Kahlenberg JM

    Nature reviews. Rheumatology 2025; (21(12)):703-718 doi:10.1038/s41584-025-01318-6.

    PMID: 41204012
  9. 9

    Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus.

    Solé C, Gimenez-Barcons M, Ferrer B, et al.

    The British journal of dermatology 2016; (175(2)):302-13 doi:10.1111/bjd.14539.

    PMID: 26972571
  10. 10

    Histologic features of chronic cutaneous lupus erythematosus of the scalp using horizontal sectioning: Emphasis on follicular findings.

    Chung HJ, Goldberg LJ

    Journal of the American Academy of Dermatology 2017; (77(2)):349-355 doi:10.1016/j.jaad.2017.02.039.

    PMID: 28624120
  11. 11

    Depression, stigma and social isolation: the psychosocial trifecta of primary chronic cutaneous lupus erythematosus, a cross-sectional and path analysis.

    Drenkard C, Theis KA, Daugherty TT, et al.

    Lupus science & medicine 2022; (9(1)) doi:10.1136/lupus-2022-000697.

    PMID: 35953237
  12. 12

    A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach.

    Jarrett P, Werth VP

    Journal of multidisciplinary healthcare 2019; (12()):419-428 doi:10.2147/JMDH.S179623.

    PMID: 31213824
  13. 13

    Cutaneous Lupus Erythematosus and Dermatomyositis: Utilizing Assessment Tools for Treatment Efficacy.

    Chong BF, Werth V

    The Journal of investigative dermatology 2022; (142(3 Pt B)):936-943 doi:10.1016/j.jid.2021.09.036.

    PMID: 34952717
  14. 14

    Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE).

    Alsukait S, Learned C, Rosmarin D

    Journal of drugs in dermatology : JDD 2023; (22(4)):425-427 doi:10.36849/JDD.7098.

    PMID: 37026882
  15. 15

    Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies.

    Wenzel J

    Nature reviews. Rheumatology 2019; (15(9)):519-532 doi:10.1038/s41584-019-0272-0.

    PMID: 31399711
  16. 16

    Halting the Progression of Cicatricial Alopecia with Injectable Platelet-Rich Fibrin.

    Chikhalkar SB, Singh S, Shah AJK, et al.

    International journal of trichology 2023; (15(4)):163-166 doi:10.4103/ijt.ijt_116_21.

    PMID: 38765723
  17. 17

    A systematic review of procedural modalities in the treatment of lichen planopilaris, frontal fibrosing alopecia, and discoid lupus erythematosus.

    Tanha AE, Ghane Y, Jafarzadeh A, Goodarzi A

    Lasers in medical science 2025; (40(1)):431 doi:10.1007/s10103-025-04704-4.

    PMID: 41081974
  18. 18

    Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.

    Foulke G, Helm LA, Clebak KT, Helm M

    FP essentials 2023; (526()):25-36.

    PMID: 36913660

This page provides long-term management and monitoring information for Discoid Lupus Erythematosus (DLE) for educational purposes only. Always consult your dermatologist for personalized medical advice and regular skin checks.

Get notified when new evidence is published on Discoid lupus erythematosus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.